Literature DB >> 18564216

Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.

Markus Hartenfeller1, Ewgenij Proschak, Andreas Schüller, Gisbert Schneider.   

Abstract

We present a fast stochastic optimization algorithm for fragment-based molecular de novo design (COLIBREE, Combinatorial Library Breeding). The search strategy is based on a discrete version of particle swarm optimization. Molecules are represented by a scaffold, which remains constant during optimization, and variable linkers and side chains. Different linkers represent virtual chemical reactions. Side-chain building blocks were obtained from pseudo-retrosynthetic dissection of large compound databases. Here, ligand-based design was performed using chemically advanced template search (CATS) topological pharmacophore similarity to reference ligands as fitness function. A weighting scheme was included for particle swarm optimization-based molecular design, which permits the use of many reference ligands and allows for positive and negative design to be performed simultaneously. In a case study, the approach was applied to the de novo design of potential peroxisome proliferator-activated receptor subtype-selective agonists. The results demonstrate the ability of the technique to cope with large combinatorial chemistry spaces and its applicability to focused library design. The technique was able to perform exploitation of a known scheme and at the same time explorative search for novel ligands within the framework of a given molecular core structure. It thereby represents a practical solution for compound screening in the early hit and lead finding phase of a drug discovery project.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564216     DOI: 10.1111/j.1747-0285.2008.00672.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  10 in total

Review 1.  De novo molecular drug design benchmarking.

Authors:  Lauren L Grant; Clarissa S Sit
Journal:  RSC Med Chem       Date:  2021-06-03

2.  e-LEA3D: a computational-aided drug design web server.

Authors:  Dominique Douguet
Journal:  Nucleic Acids Res       Date:  2010-05-05       Impact factor: 16.971

3.  Multi-objective de novo drug design with conditional graph generative model.

Authors:  Yibo Li; Liangren Zhang; Zhenming Liu
Journal:  J Cheminform       Date:  2018-07-24       Impact factor: 5.514

4.  DOGS: reaction-driven de novo design of bioactive compounds.

Authors:  Markus Hartenfeller; Heiko Zettl; Miriam Walter; Matthias Rupp; Felix Reisen; Ewgenij Proschak; Sascha Weggen; Holger Stark; Gisbert Schneider
Journal:  PLoS Comput Biol       Date:  2012-02-16       Impact factor: 4.475

5.  RENATE: A Pseudo-retrosynthetic Tool for Synthetically Accessible de novo Design.

Authors:  Gian Marco Ghiandoni; Michael J Bodkin; Beining Chen; Dimitar Hristozov; James E A Wallace; James Webster; Valerie J Gillet
Journal:  Mol Inform       Date:  2021-11-08       Impact factor: 4.050

6.  Efficient multi-objective molecular optimization in a continuous latent space.

Authors:  Robin Winter; Floriane Montanari; Andreas Steffen; Hans Briem; Frank Noé; Djork-Arné Clevert
Journal:  Chem Sci       Date:  2019-07-08       Impact factor: 9.825

7.  SYBA: Bayesian estimation of synthetic accessibility of organic compounds.

Authors:  Milan Voršilák; Michal Kolář; Ivan Čmelo; Daniel Svozil
Journal:  J Cheminform       Date:  2020-05-20       Impact factor: 5.514

Review 8.  Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.

Authors:  Varnavas D Mouchlis; Antreas Afantitis; Angela Serra; Michele Fratello; Anastasios G Papadiamantis; Vassilis Aidinis; Iseult Lynch; Dario Greco; Georgia Melagraki
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

9.  LEADD: Lamarckian evolutionary algorithm for de novo drug design.

Authors:  Alan Kerstjens; Hans De Winter
Journal:  J Cheminform       Date:  2022-01-15       Impact factor: 5.514

10.  Transformer-Based Generative Model Accelerating the Development of Novel BRAF Inhibitors.

Authors:  Lijuan Yang; Guanghui Yang; Zhitong Bing; Yuan Tian; Yuzhen Niu; Liang Huang; Lei Yang
Journal:  ACS Omega       Date:  2021-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.